publicações selecionadas
-
artigo académico
- Engineering a Hybrid Ti6Al4V-Based System for Responsive and Consistent Osteogenesis. ACS Omega. 2024
- Editorial: Disease-on-a-chip: from point-of-care to personalized medicine. Frontiers in Pharmacology. 2023
- Non-invasive diagnosis and monitoring tool of children¿s mental health: A point-of-care immunosensor for IL-6 quantification in saliva samples. Frontiers in Aging Neuroscience. 2022
- Faecal Diagnostic Biomarkers for Colorectal Cancer. Cancers. 2021
- Intratumoral VEGF nanotrapper reduces gliobastoma vascularization and tumor cell mass. Journal of Controlled Release. 2021
- Non-invasive molecular assessment of human embryo development and implantation potential. Biosensors & Bioelectronics. 2020
- Perspective: Cellular and Molecular Profiling Technologies in Personalized Oncology. Journal of Personalized Medicine. 2019
- Electrochemical Immunosensor for TNFa-Mediated Inflammatory Disease Screening. ACS Chemical Neuroscience. 2019
- Nanoparticles provide long-term stability of bevacizumab preserving its antiangiogenic activity. Acta Biomaterialia. 2018
- Collar occupancy: A new quantitative imaging tool for morphometric analysis of oligodendrocytes. Journal of Neuroscience Methods. 2018
- Mechanical plasticity during oligodendrocyte differentiation and myelination. Glia. 2017
- A new paradigm for antiangiogenic therapy through controlled release of bevacizumab from PLGA nanoparticles. Acta Cytologica. 2017
- Expression of Rac1 alternative 3' UTRs is a cell specific mechanism with a function in dendrite outgrowth in cortical neurons.. Biochimica et biophysica acta. 2017
- Cutting Edge: IFN-¿ Regulates the Induction and Expansion of IL-17-Producing CD4 T Cells during Mycobacterial Infection. Journal of Immunology. 2006
-
artigo de conferência
- PBS Finder 2015
-
artigo de revista
- IL-17A Promotes Intracellular Growth of Mycobacterium by Inhibiting Apoptosis of Infected Macrophages. Frontiers in Immunology. 2015
- BCG vaccination-induced long-lasting control of Mycobacterium tuberculosis correlates with the accumulation of a novel population of CD4<sup>+</sup>IL-17<sup>+</sup>TNF<sup>+</sup>IL-2<sup>+</sup> T cells. Vaccine. 2015
- Mycobacterium tuberculosis Strains Are Differentially Recognized by TLRs with an Impact on the Immune Response. Antibiotics. 2013
- Mycobacterium ulcerans Triggers T-Cell Immunity followed by Local and Regional but Not Systemic Immunosuppression. Infection and Immunity. 2011
- Mycobacterium ulcerans Triggers T-Cell Immunity followed by Local and Regional but Not Systemic Immunosuppression. Infection and Immunity. 2011
-
TLR2 deficiency by compromising p19 (IL-23) expression limits T
h 17 cell responses to Mycobacterium tuberculosis. International Immunology. 2011 - The selective COX-2 inhibitor Etoricoxib reduces acute inflammatory markers in a model of neurogenic laryngitis but loses its efficacy with prolonged treatment. Inflammation Research. 2010
- Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis. Journal of Experimental Medicine. 2010
- Developments on Drug Delivery Systems for the Treatment of Mycobacterial Infections. Current Topics in Medicinal Chemistry. 2008
- A New Model of Laryngitis: Neuropeptide, Cyclooxygenase, and Cytokine Profile. Laryngoscope. 2008
- Rifabutin encapsulated in liposomes exhibits increased therapeutic activity in a model of disseminated tuberculosis. International Journal of Antimicrobial Agents. 2008
- Cutting edge: IFN-γ regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection. The Journal of Immunology. 2006
-
capítulo de livro
-
documento
-
teses